Given the secreted glycoprotein role of ANGPTL2 protein, Motoyoshi and colleagues uncovered that the serum ANGPTL2 levels are significantly upregulated in breast cancer patients with metastasis and are potential predictors of metastatic breast cancer (26). This evidence concerns the gene ANGPTL2 and breast cancer.